Skip to main content

ADVERTISEMENT

David Swain, DPM, CWSP

Diabetes Watch
12/30/2019
Multiple studies link sodium-glucose cotransporter 2 (SGLT-2) inhibitors, the newest class of medications for treating diabetes, with a possible increase in lower extremity amputations.1-8 The exact cause is unknown and the research is...
Multiple studies link sodium-glucose cotransporter 2 (SGLT-2) inhibitors, the newest class of medications for treating diabetes, with a possible increase in lower extremity amputations.1-8 The exact cause is unknown and the research is...
Multiple studies link...
12/30/2019
Podiatry Today